DBD, US2536512021

Diebold Nixdorf stock gained 2.92 percent on October 5

Published on 10/06/2026 at 12:22 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Diebold Nixdorf stock has a USD 100.00 average analyst target against a USD 65.63 last price. Q2 revenue reached USD 930.8 million, with fiscal EPS guidance at USD 5.25-5.75.

DBD, US2536512021, Illustration mit AI erstellt.

Diebold Nixdorf stock (ISIN US2536512021) was last at USD 65.63 on the NYSE on October 5, 2026, up 2.92 percent from the prior session. The latest reported quarter combined USD 930.8 million in revenue with fiscal 2026 EPS guidance of USD 5.25-5.75, according to MarketBeat. The combination leaves the stock caught between improving operating figures and a sharply lower analyst view from late September.

Q2 revenue reached USD 930.8 million

For Q2 2026, Diebold Nixdorf reported diluted EPS of USD 0.44 and operating profit of USD 56.2 million. Revenue increased from USD 891.8 million in Q1 2026 to USD 930.8 million in Q2, a sequential gain of 4.4 percent based on the standardized financial statements.

MarketBeat reported that quarterly EPS matched the USD 1.10 consensus measure used in its earnings summary and that fiscal 2026 EPS guidance stood at USD 5.25-5.75. The figures point to a business with stronger quarterly revenue but a cash-sensitive execution burden as the year progresses.

Analyst targets split the outlook

Argus reduced its DBD rating to Sell on September 30, 2026, and set a USD 51.00 target, according to Yahoo Finance. That target is 22.3 percent below the October 5 last price, creating a clear contrast with the broader consensus view.

MarketBeat described a Buy consensus from three analysts with an average target of USD 100.00. The target lies 52.4 percent above the reference price, although the consensus figure predates the September 30 Sell action.

Stock stays below its yearly high

At USD 65.63, the stock stood USD 26.46 below its 52-week high of USD 92.09 and USD 11.15 above its 52-week low of USD 54.48 on October 5, 2026. Trading volume was 392,694 shares and market capitalization was USD 2.2 billion.

Diebold Nixdorf's next valuation test is the conversion of quarterly revenue into cash generation and sustained earnings. The current price reaction and the gap between the USD 51.00 Argus target and the USD 100.00 consensus target show why the company's guidance range remains central to the stock narrative.